ARCHIVES

Drug Development: ODAC Discussion May Offer Clues For Sponsors of Cytostatic Drugs

This article is from The Cancer Letter archive.

Vol. 25 No. 24 | June 16, 1999

Download PDF Visit The Full Archive

Related Articles

Suspect Chemical Include Castor Oil, Witchhazel; Details On 38 Picked For Long Term Tests

August 5, 1977

Research Needed On Hormonally Active Agents, Report Finds

August 6, 1999

NCI-Approved Group, Center Clinical Trials Listed

May 25, 2007

Studies Test New Agents Offering Relief From Treatment-Related Side Effects

July 30, 2004

Phase III Nexavar Trial Fails Primary Endpoint

August 29, 2014

House Approves Waxman Bill Unanimously; Hatch Introduces His Measure

June 21, 1985